HealthTree®

IMPROVING MYELOMA PATIENT OUTCOMES AND ACCELERATING A CURE

LIFE WITH MYELOMA

HealthTree for Multiple Myeloma Featured on the Today Show

Mar 20, 2019
March 20, 2019 The Today Show featured Jenny and Paul Ahlstrom as they described a new patient platform they created called HealthTree. The mission of HealthTree is to help doctors, researchers and...
ADVERTISEMENT
CLINICAL TRIALS

Clinical Trial: Using a Vaccine PVX-410 with Citarinostat +/- Lenalidomide for Smoldering Multipl...

Mar 08, 2019
A Phase I study of a vaccine called PVX-410 for patients with moderate/high risk Smoldering Multiple Myeloma is open. PVX-410 is...
SIGN UP FOR OUR
NEWSLETTER
Get the latest thought leadership on multiple myeloma delivered straight to your inbox.

GO

LIFE WITH MYELOMA
Mar 18, 2019
  You have cancer.  No one ever expects to hear those...
MYELOMA CROWD RADIO

Full Show: A New CD38 Monocloncal Antibody Called Isatuximab Gets Closer to the Clinic, with Ravi Vij, MD, Washington...

Feb 19, 2019
Ravi Vij, MD Washington University Interview Date: February 6, 2019 Summary A new CD38 targeted...
MYELOMA CROWD RESEARCH INITIATIVE
$118683 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal
MYELOMA 101

What Is Relapsed vs. Refractory Myeloma?

Feb 02, 2019
There are so many myeloma phrases, terminology and acronyms that things can get incredibly confusing. Let’s talk about Relapsed Myeloma (sort of self...
MUSCLES FOR MYELOMA

Bike the Coast June 2019 – An Epic Cycling Event From San Francisco to San Diego to Fund My...

Feb 27, 2019
Join us this summer to Bike the Coast to raise funds for multiple myeloma research! This epic event will include a ride from San Francisco to San Diego – 100 miles a day for 6 days. Ride as much or as little as you’d like. We have each...
CLINICAL TRIALS

Clinical Trial: Overall Survival Lengthened for Relapsed/Refractory Myeloma Patients Using CLR 131 Cancer-Targeted Th...

Feb 02, 2019
Myeloma patients who had relapsed after receiving both a proteasome inhibitor (like Velcade) and immunomodulator (like Revlimid) participated in a Phase I study of a new drug called CLR 131 and experienced an average 22 month overall...

FIND

Myeloma Financial Resource
FINANCIAL
RESOURCES
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Myeloma Specialist
MYELOMA
SPECIALISTS
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
Myeloma Clinical Trials
CLINICAL
TRIALS
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.

MYELOMA CROWD RESEARCH INITIATIVE

The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.
Learn More >

Thanks to our site sponsors: